pravastatin has been researched along with Hyperplasia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banno, H; Fujita, H; Kobayashi, M; Komori, K; Kuwano, H; Nakayama, M; Sugimoto, M; Yamanouchi, D | 1 |
| Arakawa, E; Hasegawa, K; Ina, Y; Matsubara, M; Takada, C; Takayama, M; Yao, K | 1 |
| Fukami, M; Fukushige, J; Hosokawa, T; Ito, T; Shiomi, M; Tamura, A; Tsujita, Y; Tsukada, T; Watanabe, Y; Yata, T | 1 |
| Bannenberg, G; Bueld, JE; Netter, KJ | 1 |
| Bandoh, T; Hayashi, S; Ishikawa, J; Kimura, M; Kusumi, Y; Mitani, H; Niihashi, M; Sakurai, I; Totsuka, T | 1 |
| Imagawa, DK; Si, MS | 1 |
6 other study(ies) available for pravastatin and Hyperplasia
| Article | Year |
|---|---|
Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
Topics: Animals; Biopsy, Needle; Cell Proliferation; Disease Models, Animal; Graft Rejection; Graft Survival; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperplasia; Immunohistochemistry; In Situ Nick-End Labeling; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Jugular Veins; Male; Pravastatin; Preoperative Care; Probability; Protein Serine-Threonine Kinases; Rabbits; Random Allocation; Reference Values; rho-Associated Kinases; Risk Factors; Sensitivity and Specificity; Tunica Intima; Vascular Surgical Procedures | 2005 |
Comparison of the antiatherosclerotic effects of dihydropyridine calcium channel blocker and HMG-CoA reductase inhibitor on hypercholesterolemic rabbits.
Topics: Animals; Aorta, Thoracic; Atherosclerosis; Calcium Channel Blockers; Cholesterol; Dihydropyridines; Disease Models, Animal; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperplasia; Male; Pravastatin; Rabbits; RNA, Messenger; Scavenger Receptors, Class E; Time Factors; Tunica Intima; Up-Regulation; Vascular Cell Adhesion Molecule-1; Vasodilation | 2007 |
Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques. Effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits.
Topics: Animals; Anticholesteremic Agents; Aorta; Arteriosclerosis; Cholesterol; Coronary Vessels; Hyperlipidemias; Hyperplasia; Macrophages; Muscle, Smooth, Vascular; Pravastatin; Rabbits | 1995 |
Effects of propionic acid and pravastatin on HMG-CoA reductase activity in relation to forestomach lesions in the rat.
Topics: Animals; Cholesterol; Enzyme Induction; Gastric Mucosa; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperplasia; Hypolipidemic Agents; Male; Microsomes; Pravastatin; Propionates; Rats; Rats, Wistar; Stomach Diseases | 1996 |
Inhibitory effect of fluvastatin at doses insufficient to lower serum lipids on the catheter-induced thickening of intima in rabbit femoral artery.
Topics: Animals; Anticholesteremic Agents; Catheterization; Cholesterol; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Femoral Artery; Fluvastatin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperplasia; Indoles; Lipids; Male; Mevalonic Acid; Phospholipids; Pravastatin; Rabbits; Triglycerides; Tunica Intima | 1996 |
Prenylation inhibitors to treat proliferative renal disease.
Topics: Animals; Drug Evaluation, Preclinical; Graft Rejection; Hyperplasia; Immunosuppressive Agents; Kidney Diseases; Lymphocyte Activation; Monoterpenes; Pravastatin; Protein Prenylation; Rats; T-Lymphocytes; Terpenes | 2000 |